Page 197 - Tata_Chemicals_yearly-reports-2021-22

01 INTEGRATED 73 STATUTORY 178 FINANCIAL
REPORT
REPORTS
STATEMENTS
Standalone

Standalone Statement of Cash Flows for the year ended March 31, 2022

` in crore
Year ended Year ended
Particulars
March 31, 2022 March 31, 2021
A Cash flows from operating activities
Profit before tax from continuing operations 987.61 613.97
Profit before tax from discontinued operations 28.37 -
1,015.98 613.97
Adjustments for :
Depreciation and amortisation expense 222.41 197.32
Finance costs 19.28 18.74
Interest income (110.41) (47.34)
Dividend income (82.95) (72.91)
Net gain on sale of current investments (45.85) (45.82)
Provision for employee benefits expense 7.84 30.05
Provision for doubtful debts and advances/bad debts written off (net) 0.33 0.18
Provision for contingencies (net) 13.79 7.12
Liabilities no longer required written back (2.20) (3.25)
Foreign exchange (gain)/loss (net) (5.33) 4.15
Loss on assets sold or discarded (net) 4.00 2.78
Operating profit before working capital changes 1,036.89 704.99
Adjustments for :
Trade receivables, other financial assets and other assets 20.23 58.38
Inventories (358.10) 179.53
Trade payables, other financial liabilities and other liabilities 68.39 (120.09)
Cash generated from operations 767.41 822.81
Taxes paid (net of refund) (185.66) (151.06)
Net cash generated from operating activities 581.75 671.75
B Cash flows from investing activities
Acquisition of property, plant and equipment (including capital work-in-progress) (776.22) (546.87)
Acquisition of intangible assets (including intangible asset under development) (7.47) (3.77)
Proceeds from sale of property, plant and equipment 6.55 0.54
Proceeds from sale of other non-current investments 74.60 -
Proceeds from sale of current investments 4,443.52 3,335.53
Purchase of non-current investments (132.48) (198.90)
Purchase of current investments (4,229.21) (3,269.99)
Bank balances not considered as cash and cash equivalents (net) 148.42 169.99
Interest received 34.19 37.76
Dividend received
- From subsidiaries 29.20 26.33
- From joint venture 27.87 26.49
- From others 25.88 20.09
Net cash used in investing activities (355.15) (402.80)

195